APP and Alzheimer disease: An in vivo study carried out in mice to connect diabetes mellitus and AD explained that the subjects injected with AGEs demonstrated depleting memory capacity and accumulation of indicators like tau phosphorylation and APP (amyloid precursor protein) antibodies [32].